Cargando…
Drug information update. Lithium and chronic kidney disease: debates and dilemmas
Lithium is an established treatment for bipolar disorder and an augmenting agent for treatment-resistant depression. Despite awareness of renal adverse effects, including chronic kidney disease, for the past five decades, there has been a lack of research evidence. This has led to debates around the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Royal College of Psychiatrists
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537577/ https://www.ncbi.nlm.nih.gov/pubmed/28811917 http://dx.doi.org/10.1192/pb.bp.116.054031 |